AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17717235 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 300 mL vs 50 mL water
Number of subjects: 10
Study 15305335 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioavailable testosterone levels
Number of subjects: 320
Study 15305335 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol/bioavailable testosterone ratio
Number of subjects: 320
Study 15305335 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol levels
Number of subjects: 320
Study 11724848 — intervention group
Group type: EXPERIMENTAL
Intervention: MYCO/F Lytic bottle
Number of subjects: 6108
Study 11724848 — intervention group
Group type: COMPARATOR
Intervention: Isolator system
Number of subjects: 6108
Study 11724848 — intervention group
Group type: EXPERIMENTAL
Intervention: BACTEC Plus Aerobic/F bottle
Number of subjects: 6108
Study 11724848 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Isolator system and MYCO/F Lytic bottle
Number of subjects: 6108
Study 9666944 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride therapy
Number of subjects: 0
Study 9666944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7980801 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment E
Number of subjects: 0
Study 7980801 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy S
Number of subjects: 0
Study 3060193 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin 20 mg three times a day for 1 week, then 40 mg three times a day for 4 weeks
Number of subjects: 9
Study 3060193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31128269 — intervention group
Group type: EXPERIMENTAL
Intervention: TeachTown: Basics (computer-assisted intervention), 20 minutes per day for 3 months
Number of subjects: 22
Study 31128269 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 30460354 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cement (RMGIC) with fluoride toothpaste
Number of subjects: 60
Study 30460354 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass carbomer with fluoride toothpaste
Number of subjects: 60
Study 30460354 — intervention group
Group type: EXPERIMENTAL
Intervention: Giomer
Number of subjects: 60
Study 30460354 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fluoride toothpaste)
Number of subjects: 60
Study 28947468 — intervention group
Group type: EXPERIMENTAL
Intervention: High DHA fish oil capsules
Number of subjects: 5540
Study 28947468 — intervention group
Group type: COMPARATOR
Intervention: Control capsules without DHA
Number of subjects: 5540
Study 26373743 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus acidophilus, Enterococcus faecium and Bifidobacterium infantum) at a dose of 0.6 × 107 colony‐forming units twice daily
Number of subjects: 80
Study 26373743 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus acidophilus, Enterococcus faecium and Bifidobacterium infantum)
Number of subjects: 80
Study 26373743 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probiotics)
Number of subjects: 80
Study 22647247 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish protein supplement (3 g/d for the first 4 weeks and 6 g/d for the last 4 weeks)
Number of subjects: 34
Study 21638149 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 g ginger extracts
Number of subjects: 0
Study 19047538 — intervention group
Group type: COMPARATOR
Intervention: Behavioral parent-only intervention
Number of subjects: 93
Study 19047538 — intervention group
Group type: COMPARATOR
Intervention: Behavioral family-based intervention
Number of subjects: 93
Study 17137894 — intervention group
Group type: EXPERIMENTAL
Intervention: Antistatic valved holding chamber/mask (AeroChamber MAX)
Number of subjects: 12
Study 17137894 — intervention group
Group type: COMPARATOR
Intervention: Conventional valved holding chamber/mask (AeroChamber Plus)
Number of subjects: 12
Study 12585986 — intervention group
Group type: EXPERIMENTAL
Intervention: Duct tape
Number of subjects: 0
Study 12585986 — intervention group
Group type: COMPARATOR
Intervention: Traditional cryotherapy
Number of subjects: 0
Study 10861274 — intervention group
Group type: EXPERIMENTAL
Intervention: CT colonography (VC)
Number of subjects: 50
Study 10861274 — intervention group
Group type: COMPARATOR
Intervention: Conventional colonoscopy (CC)
Number of subjects: 50
Study 9188991 — intervention group
Group type: EXPERIMENTAL
Intervention: Trackball operation with free head movements
Number of subjects: 18
Study 9188991 — intervention group
Group type: COMPARATOR
Intervention: Trackball operation with fixed head (using only jaw muscles)
Number of subjects: 18
Study 1336762 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral itraconazole 200 mg daily for five days, then 200 mg twice weekly for six months
Number of subjects: 44
Study 1336762 — intervention group
Group type: COMPARATOR
Intervention: Intravaginal clotrimazole 200 mg ovules daily for five days, then 200 mg twice weekly for six months
Number of subjects: 44
Study 1336762 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral itraconazole after discontinuation of therapy
Number of subjects: 44
Study 1336762 — intervention group
Group type: COMPARATOR
Intervention: Intravaginal clotrimazole after discontinuation of therapy
Number of subjects: 44
Study 3799209 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 0.5 mg
Number of subjects: 9
Study 3799209 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 9
Study 3799209 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg
Number of subjects: 9
Study 3799209 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31016503 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom videos
Number of subjects: 804
Study 31016503 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer norms growth trajectories
Number of subjects: 804
Study 31016503 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy growth trajectories
Number of subjects: 804
Study 31016503 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom use behavior growth trajectories
Number of subjects: 804
Study 29230665 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 years of extended letrozole
Number of subjects: 1824
Study 29230665 — intervention group
Group type: COMPARATOR
Intervention: 2.5 years of extended letrozole
Number of subjects: 1824
Study 27395054 — intervention group
Group type: EXPERIMENTAL
Intervention: 45-kg thoracic loading
Number of subjects: 19
Study 27395054 — intervention group
Group type: COMPARATOR
Intervention: Unloaded condition
Number of subjects: 19
Study 27395054 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 kg load
Number of subjects: 19
Study 27395054 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 kg load
Number of subjects: 19
Study 27395054 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 kg load
Number of subjects: 19
Study 24901386 — intervention group
Group type: EXPERIMENTAL
Intervention: PAH-related hospitalization
Number of subjects: 862
Study 24901386 — intervention group
Group type: EXPERIMENTAL
Intervention: PAH-unrelated hospitalization
Number of subjects: 862
Study 22248375 — intervention group
Group type: EXPERIMENTAL
Intervention: Bizarre sentences presented to young and older adults under incidental recall conditions in Experiment 1
Number of subjects: 0
Study 22248375 — intervention group
Group type: EXPERIMENTAL
Intervention: Bizarre sentences presented to young and older adults under intentional learning conditions in Experiment 2
Number of subjects: 0
Study 21313929 — intervention group
Group type: EXPERIMENTAL
Intervention: Vicarious audiovisual learning (video)
Number of subjects: 37
Study 21313929 — intervention group
Group type: COMPARATOR
Intervention: Text learning (control)
Number of subjects: 37
Study 18345398 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril alone or cilazapril/hydrochlorothiazide/amlodipine combination therapy
Number of subjects: 49
Study 16223944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients' intestinal biopsies
Number of subjects: 12
Study 14561263 — intervention group
Group type: EXPERIMENTAL
Intervention: InSure test (brush-based faecal immunochemical test)
Number of subjects: 46
Study 14561263 — intervention group
Group type: COMPARATOR
Intervention: FlexSure OBT test (traditional spatula-sampling immunochemical test)
Number of subjects: 46
Study 10626972 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral thoracodorsal flap
Number of subjects: 75
Study 10626972 — intervention group
Group type: EXPERIMENTAL
Intervention: Latissimus dorsi flap
Number of subjects: 75
Study 10626972 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAM flap
Number of subjects: 75
Study 10626972 — intervention group
Group type: EXPERIMENTAL
Intervention: All methods
Number of subjects: 75
Study 9366768 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate
Number of subjects: 42
Study 9366768 — intervention group
Group type: COMPARATOR
Intervention: Sodium heparin, EDTA, lithium heparin
Number of subjects: 42
Study 9366768 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma and serum samples
Number of subjects: 42
Study 9366768 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma vs. whole blood
Number of subjects: 42
Study 9366768 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum vs. plasma
Number of subjects: 42
Study 1567264 — intervention group
Group type: EXPERIMENTAL
Intervention: Diminazene aceturate (Berenyl)
Number of subjects: 66
Study 1567264 — intervention group
Group type: COMPARATOR
Intervention: Cetrimide 15% + chlorhexidine 1.5% (Savlon)
Number of subjects: 66
Study 3935455 — intervention group
Group type: EXPERIMENTAL
Intervention: Metolazone (2.5 mg orally after 6 hours of furosemide infusion)
Number of subjects: 8
Study 3935455 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (4 mg h‐1 intravenous infusion for 12 hours)
Number of subjects: 8
Study 30379387 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (tDCS) over right Broca's area
Number of subjects: 0
Study 30379387 — intervention group
Group type: COMPARATOR
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 0
Study 30379387 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 30082326 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide QW (2-mg subcutaneous injection) plus dapagliflozin (10-mg oral tablet)
Number of subjects: 695
Study 30082326 — intervention group
Group type: COMPARATOR
Intervention: Exenatide QW (2-mg subcutaneous injection)
Number of subjects: 695
Study 30082326 — intervention group
Group type: COMPARATOR
Intervention: Dapagliflozin (10-mg oral tablet)
Number of subjects: 695
Study 27923401 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO Safe Childbirth Checklist (SCC) embedded in a quality improvement program, including leadership engagement, a 2-day educational launch, and support from a trained peer coach over an 8-month period.
Number of subjects: 171964
Study 27923401 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO Safe Childbirth Checklist (SCC)
Number of subjects: 171964
Study 27923401 — intervention group
Group type: COMPARATOR
Intervention: Control group (60 sites without the SCC intervention)
Number of subjects: 171964
Study 24780614 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone (25-50 mg once daily)
Number of subjects: 1012
Study 24780614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1012
Study 21862447 — intervention group
Group type: EXPERIMENTAL
Intervention: Word listening task with auditory stimuli
Number of subjects: 0
Study 21862447 — intervention group
Group type: COMPARATOR
Intervention: Younger adults
Number of subjects: 0
Study 21862447 — intervention group
Group type: COMPARATOR
Intervention: Middle-aged adults
Number of subjects: 0
Study 21862447 — intervention group
Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 0
Study 19579199 — intervention group
Group type: EXPERIMENTAL
Intervention: BioGlue™ for mesh fixation
Number of subjects: 60
Study 19579199 — intervention group
Group type: COMPARATOR
Intervention: Conventional suture for mesh fixation
Number of subjects: 60
Study 17846938 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated primary care model for COPD
Number of subjects: 260
Study 17846938 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 260
Study 15084974 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 42
Study 15084974 — intervention group
Group type: COMPARATOR
Intervention: Radiochemotherapy
Number of subjects: 42
Study 11395821 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 106
Study 11395821 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy (OA)
Number of subjects: 106
Study 9755021 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound, massage and exercise (group A)
Number of subjects: 58
Study 9755021 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham-ultrasound, massage and exercise (group B)
Number of subjects: 58
Study 9755021 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 58
Study 9755021 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 58
Study 9755021 — intervention group
Group type: COMPARATOR
Intervention: Treatment groups (A and B) vs Control group (C)
Number of subjects: 58
Study 8116577 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin-layer processing device
Number of subjects: 3218
Study 8116577 — intervention group
Group type: COMPARATOR
Intervention: Conventional smear
Number of subjects: 3218
Study 3041785 — intervention group
Group type: EXPERIMENTAL
Intervention: Terodiline hydrochloride (24 mg/day)
Number of subjects: 199
Study 3041785 — intervention group
Group type: COMPARATOR
Intervention: Flavoxate hydrochloride (600 mg/day)
Number of subjects: 199
Study 30669199 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/3 octave
Number of subjects: 90
Study 30669199 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/12 octave
Number of subjects: 90
Study 30669199 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/24 octave
Number of subjects: 90
Study 28292867 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy with Solitaire FR Device
Number of subjects: 206
Study 28292867 — intervention group
Group type: COMPARATOR
Intervention: Best Medical Therapy (Control)
Number of subjects: 206
Study 28292867 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 206
Study 26620188 — intervention group
Group type: EXPERIMENTAL
Intervention: Action or Maintenance stages
Number of subjects: 504
Study 26620188 — intervention group
Group type: COMPARATOR
Intervention: Precontemplation stage
Number of subjects: 504
Study 26620188 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance stage
Number of subjects: 504
Study 26620188 — intervention group
Group type: EXPERIMENTAL
Intervention: All stages
Number of subjects: 504
Study 22789872 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual healthcare education program (12-week duration)
Number of subjects: 190
Study 22789872 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 190
Study 21944653 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (12 sessions of 30 minutes each)
Number of subjects: 93
Study 21944653 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard rehabilitation without acupuncture)
Number of subjects: 93
Study 20078940 — intervention group
Group type: COMPARATOR
Intervention: 2827C>T polymorphism in the prostasin gene
Number of subjects: 938
Study 20078940 — intervention group
Group type: EXPERIMENTAL
Intervention: E342K mutation in the prostasin gene
Number of subjects: 938
Study 16376092 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary shunt
Number of subjects: 40
Study 16376092 — intervention group
Group type: COMPARATOR
Intervention: Shuntless anastomosis
Number of subjects: 40
Study 15223882 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resistance training (HT)
Number of subjects: 33
Study 15223882 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-resistance training (MT)
Number of subjects: 33
Study 15223882 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study 11475801 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Drug Monitoring (TDM)
Number of subjects: 0
Study 11475801 — intervention group
Group type: EXPERIMENTAL
Intervention: Target Concentration Intervention (TCI)
Number of subjects: 0
Study 11475801 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised Concentration Controlled Trials (RCCT)
Number of subjects: 0
Study 9250283 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN + UDCA
Number of subjects: 41
Study 9250283 — intervention group
Group type: COMPARATOR
Intervention: IFN
Number of subjects: 41
Study 8490549 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammographic screening
Number of subjects: 0
Study 3557003 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (50 mg oral doses for 4 days)
Number of subjects: 0
Study 3557003 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (100 mg single oral dose)
Number of subjects: 0
Study 3557003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31329610 — intervention group
Group type: EXPERIMENTAL
Intervention: MERM device with daily alert and scheduled dosing history review
Number of subjects: 20
Study 31329610 — intervention group
Group type: COMPARATOR
Intervention: MERM device without an alert
Number of subjects: 20
Study 28684083 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil
Number of subjects: 0
Study 28684083 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with mixed-nuts
Number of subjects: 0
Study 28684083 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 26082623 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with long-acting anticholinergic drugs
Number of subjects: 0
Study 26082623 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant systemic corticosteroids for the current exacerbation
Number of subjects: 0
Study 23515006 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (1.16 g DHA/d)
Number of subjects: 176
Study 23515006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 21242737 — intervention group
Group type: EXPERIMENTAL
Intervention: PHMB foam dressing
Number of subjects: 45
Study 21242737 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-antimicrobial foam)
Number of subjects: 45
Study 18188660 — intervention group
Group type: EXPERIMENTAL
Intervention: aerobic exercise + home exercise
Number of subjects: 60
Study 18188660 — intervention group
Group type: EXPERIMENTAL
Intervention: physical therapy (hot pack, ultrasound, TENS) + home exercise
Number of subjects: 60
Study 18188660 — intervention group
Group type: COMPARATOR
Intervention: home exercise only
Number of subjects: 60
Study 16869219 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 12923829 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (12 or 18 mg/day)
Number of subjects: 17
Study 12923829 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (6 mg/day)
Number of subjects: 17
Study 12923829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 11100393 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose adrenomedullin (ADM, 1, 2 and 3 pmol kg‐1 min‐1 for 30 min each)
Number of subjects: 6
Study 11100393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 8874298 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients treated in 1988 to 1990 with three or more organ system failures on day 4 or later of organ system failure
Number of subjects: 17440
Study 8874298 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients treated in 1988 to 1990
Number of subjects: 17440
Study 8874298 — intervention group
Group type: COMPARATOR
Intervention: Patients treated in 1979 to 1982
Number of subjects: 17440
Study 8874298 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic scoring system on day 1 of organ system failure
Number of subjects: 17440
Study 8874298 — intervention group
Group type: EXPERIMENTAL
Intervention: Model based on the number of organ system failures
Number of subjects: 17440
Study 1445824 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals based on steam-cooked semolina
Number of subjects: 30
Study 1445824 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals based on semolina-Bengal gram dhal
Number of subjects: 30
Study 1445824 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals based on semolina-black gram dhal
Number of subjects: 30
Study 1445824 — intervention group
Group type: COMPARATOR
Intervention: Conventional Indian meals (various types)
Number of subjects: 30
Study 3901956 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral electroconvulsive therapy (ECT)
Number of subjects: 48
Study 3901956 — intervention group
Group type: COMPARATOR
Intervention: Nondominant unilateral electroconvulsive therapy (ECT)
Number of subjects: 48
Study 29926979 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri 6475 (1010 colony-forming units daily)
Number of subjects: 90
Study 29926979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 27689192 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-dose regimen of sodium picosulfate/magnesium citrate (SPMC)
Number of subjects: 315
Study 27689192 — intervention group
Group type: COMPARATOR
Intervention: Prior-day schedule (AM/PM)
Number of subjects: 315
Study 27689192 — intervention group
Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 315
Study 25362223 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (enoxaparin), 0.5 mg/kg at the beginning of each hemodialysis session
Number of subjects: 58
Study 25362223 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UF heparin), 5000 units
Number of subjects: 58
Study 22647278 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumping exercise intervention (supervised jumping protocol during the first 10 min of physical education class, twice a week for 9 months)
Number of subjects: 43